KRAS and colorectal cancer: Sakai and coworkers generated mouse models harboring different combinations of key colorectal cancer driver mutations (APC, KRAS, TGFBR2, TP53 and FBXW7) in intestinal cells to investigate their role in the development of primary tumors and metastases.